Latest News

To analyse the optimal time cut-off for determining positivity of dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) in peripheral zone (PZ) prostate cancer (PCa). A consecutive series of 89 patients with PZ PCa who had undergone diffusion-weighted imaging (DWI) and subtraction DCE MRI were included. An experienced reader visually analysed the earliest time after contrast […]

Incidence rates of testicular cancer (TC) have been increasing in many countries since, at least, the mid-20th century without clear explanation. Examining the varying trends across countries and time provides clues to understanding the causes of TC. We have presented incidence data from 41 countries and evaluated incidence trends for the 35-yr period from 1978 […]

Alicia Morgans: Hi, I’m thrilled to have here with me today, Brittany Szymaniak who’s a genetic counselor in the Department of Urology at Northwestern Medicine where we work together. So nice to have you here. Brittany Szymaniak: Thanks for having me, Alicia. I really appreciate it. Alicia Morgans: Of course. So I am so excited […]

Gordon Brown: Hello, I’m Gordon Brown from New Jersey Urology here today with Dr. Eric Ballon-Landa of the University of California San Diego. He’s a rising chief resident attending the Large Urology Group Practice Association Summit for a Rising Chief Residents. We’re here today to talk about tips and tricks around the interview process for […]

Petros Grivas: Hello. I’m Dr. Petros Grivas. I’m a medical oncologist at Seattle Cancer Care Alliance and Associate Professor of Medicine at the University of Washington and Associate Member of the Fred Hutchinson Cancer Research Center. I’m really thrilled and honored today to host Dr. Guru Sonpavde, who’s the director of the Bladder Cancer Program […]

Urothelial cell carcinoma (UCC) of the bladder is exceedingly rare in pediatric patients. Limited data are available to guide management in this population. The authors systematically searched MEDLINE, Cochrane Library, and Google Scholar (through February 2019) for case reports and series to summarize data regarding presentation, evaluation, management, and follow-up for patients ≤ 18 years diagnosed with […]

The Caribbean is made up of several independent nations and the availability of urology and more specifically endourology services varies widely between them. In this article we explore the history and current state of endourology in the English speaking Caribbean as well as the challenges faced within the region many of which are shared by […]

Salvage lymph node dissection (SLND) is still a questionable treatment approach for patients with nodal recurrence of prostate cancer after radical prostatectomy. We assessed the oncological benefit after SLND in hormone-naïve patients as well as the diagnostic accuracy of preoperative prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography (PET/CT) scanning. The study relied on retrospective […]

The theranostic concept represents a paradigmatic example of personalized treatment. It is based on the use of radiolabeled compounds which can be applied for both diagnostic molecular imaging and subsequent treatment, using different radionuclides for labelling. Clinically relevant examples include somatostatin receptor (SSTR)-targeted imaging and therapy for the treatment of neuroendocrine tumors (NET), as well […]